Clinical Trial Update: Inqovi Maintenance Therapy in Myeloid Neoplasms [Phase 1]

View source ↗

Summary

Phase 1 trial update on Inqovi as maintenance therapy for myeloid neoplasms, including myelodysplastic syndromes and chronic myelomonocytic leukemia, with the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• Inqovi (decitabine/cedazuridine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING